Zonisamide for fibromyalgia and migraine.

Trial Profile

Zonisamide for fibromyalgia and migraine.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 31 May 2011

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Fibromyalgia; Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2011 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 31 May 2011 Last checked against ClinicalTrials.gov record.
    • 12 Nov 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top